Where Does Wall Street Think Solid Biosciences Inc (SLDB) Stock Will Go?

Analysts who follow Solid Biosciences Inc (SLDB) on average expect it to climb 733.33% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Solid Biosciences Inc an Analyst Ranking of 27, which means it ranks higher than 27 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating SLDB a Buy today. Find out what this means to you and get the rest of the rankings on SLDB!

See Full SLDB Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With Solid Biosciences Inc Stock Today?

Solid Biosciences Inc (SLDB) stock is trading at $0.78 as of 12:00 PM on Thursday, Aug 11, an increase of $0.03, or 3.89% from the previous closing price of $0.75. The stock has traded between $0.75 and $0.80 so far today. Volume today is 522,339 compared to average volume of 474,001. Click Here to get the full Stock Report for Solid Biosciences Inc stock.